Cytokine gene polymorphism in human disease: on-line databases

[1]  F. Pociot,et al.  Cytokine gene polymorphism in human disease: on-line databases, Supplement 1 , 2001, Genes and Immunity.

[2]  M. Eaman.  Immune system. , 2000, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[3]  J. Bidwell,et al.  An association between LSIL and the high secretor phenotype of IL-1beta. , 1999, Gynecologic oncology.

[4]  N. Freimer,et al.  Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. , 1999, American journal of human genetics.

[5]  Ian Todd,et al.  Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes , 1999, Cell.

[6]  J. Bidwell,et al.  Human cytokine gene nucleotide sequence alignments: supplement 1. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[7]  T. Wienker,et al.  Promoter polymorphism at -238 of the tumor necrosis factor alpha gene is not associated with early onset psoriasis when tested by the transmission disequilibrium test. , 1999, The Journal of investigative dermatology.

[8]  E. Trabetti,et al.  Association of a lymphotoxin α gene polymorphism and atopy in Italian families , 1999, Journal of medical genetics.

[9]  H. Niiro,et al.  Association of the interferon-γ receptor variant (Val14Met) with systemic lupus erythematosus , 1999, Immunogenetics.

[10]  M. Hurme,et al.  Polymorphisms of the interleukin-1 gene complex in schizophrenia , 1999, Molecular Psychiatry.

[11]  G. Pawelec,et al.  T cells and aging (update february 1999). , 1999, Frontiers in bioscience : a journal and virtual library.

[12]  N. Camp,et al.  Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. , 1999, Circulation.

[13]  P. Pisa,et al.  Tumour necrosis factor‐α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia , 1999 .

[14]  K. Mendis,et al.  TNFα*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans , 1999, Clinical and experimental immunology.

[15]  A. Hajeer,et al.  In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. , 1999, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[16]  P. Donaldson,et al.  Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. , 1999, Journal of hepatology.

[17]  A. Peña,et al.  Genetic markers in clinically well defined patients with ulcerative colitis (UC). , 1998, Clinical and experimental immunology.

[18]  V. Sharma,et al.  TGF-β1 DNA Polymorphisms, Protein Levels, and Blood Pressure , 1999 .

[19]  T. Shirakawa,et al.  Signal transduction via the interleukin-4 receptor and its correlation with atopy. , 1999, International journal of molecular medicine.

[20]  H. Niiro,et al.  Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus. , 1999, Immunogenetics.

[21]  P. Pisa,et al.  Tumour necrosis factor-alpha cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukaemia. , 1999, British journal of haematology.

[22]  K. Schwarz,et al.  Mutations in the gene for the common gamma chain (γc) in X-linked severe combined immunodeficiency , 1998, Human Genetics.

[23]  P. Tonali,et al.  Tumour necrosis factor beta gene polymorphisms in myasthenia gravis. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[24]  J. Ihle,et al.  Signaling by the Cytokine Receptor Superfamily a , 1998, Annals of the New York Academy of Sciences.

[25]  F. Pociot,et al.  TGF-beta1 gene mutations in insulin-dependent diabetes mellitus and diabetic nephropathy. , 1998, Journal of the American Society of Nephrology : JASN.

[26]  M. Klinnert,et al.  Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma , 1998 .

[27]  R. Pirskanen,et al.  No evidence for interleukin-4 gene conferring susceptibility to myasthenia gravis , 1998, Journal of Neuroimmunology.

[28]  D. Middleton,et al.  An interluekin 1B allele, which correlates with a high secretor phenotype, is associated with diabetic nephropathy. , 1998, Cytokine.

[29]  S. John,et al.  Two novel biallelic polymorphisms in the IL-2 gene. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[30]  M. Emi,et al.  A highly polymorphic CA repeat marker at the human interleukin 6 receptor (IL6R) locus , 1998, Journal of Human Genetics.

[31]  G. Jackson,et al.  Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. , 1998, Blood.

[32]  H. Budka,et al.  Development of HIV encephalitis in AIDS and TNF-α regulatory elements , 1998, Journal of Neuroimmunology.

[33]  K. Usadel,et al.  Interferon-γ Gene Microsatellite Polymorphisms in Patients with Graves' Disease , 1998 .

[34]  H. Kawakami,et al.  Genetic contribution of the tumor necrosis factor region in guillain‐barré syndrome , 1998, Annals of neurology.

[35]  P. Hasleton,et al.  Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. , 1998, Transplantation.

[36]  Paul Wordsworth,et al.  Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility , 1998, The Lancet.

[37]  D. Linch,et al.  Activating point mutations in the βC chain of the GM‐CSF, IL‐3 and IL‐5 receptors are not a major contributory factor in the pathogenesis of acute myeloid leukaemia , 1998, British journal of haematology.

[38]  K. Ikeda,et al.  Association of a Polymorphism of the Transforming Growth Factor‐β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  Y. Palesch,et al.  Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis. , 1998, Journal of clinical periodontology.

[40]  P. Borm,et al.  Polymorphisms in the promoter of the tumor necrosis factor-alpha gene in coal miners. , 1998, American journal of industrial medicine.

[41]  D. Hartl,et al.  Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. , 1998, Tissue antigens.

[42]  T. Spector,et al.  Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. , 1998, Bone.

[43]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[44]  W. Ollier,et al.  Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty's syndrome. , 1998, British journal of rheumatology.

[45]  Hurme,et al.  Polymorphism of the IL‐1 Gene Complex in Epstein–Barr Virus Seronegative and Seropositive Adult Blood Donors , 1998, Scandinavian journal of immunology.

[46]  R. Westendorp,et al.  Interleukin 10 secretion in relation to human IL-10 locus haplotypes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Hurme,et al.  IL‐1 receptor antagonist (IL‐1Ra) plasma levels are co‐ordinately regulated by both IL‐1Ra and IL‐1β genes , 1998 .

[48]  Simon,et al.  Ultraviolet B induced suppression of induction of contact sensitivity in human skin is not associated with tumour necrosis factor‐alpha‐308 or interleukin‐10 genetic polymorphisms , 1998 .

[49]  C. Peacock,et al.  Polymorphism in tumor necrosis factor genes associated with myasthenia gravis , 1998, Journal of Neuroimmunology.

[50]  P. Barnes,et al.  Haplotype associated with low interleukin-10 production in patients with severe asthma , 1998, The Lancet.

[51]  Winkelmann,et al.  Tumour necrosis factor β alleles and hyperinsulinaemia in coronary artery disease , 1998 .

[52]  M. Parkes,et al.  Contribution of the IL‐2 and IL‐10 genes to inflammatory bowel disease (IBD) susceptibility , 1998, Clinical and experimental immunology.

[53]  K. Kornman,et al.  Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. , 1998, Annals of periodontology.

[54]  H. Kremer,et al.  The role of the Th-1 to Th-2 shift of the cytokine profiles of CD4 helper cells in the pathogenesis of autoimmune and hypercatabolic diseases. , 1998, Medical hypotheses.

[55]  J. Martín,et al.  Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease. , 1998, Tissue antigens.

[56]  R. Kralovics,et al.  Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. , 1998, The Journal of clinical investigation.

[57]  P. Reitsma,et al.  Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease , 1998, Gut.

[58]  D. Mann,et al.  Effects of Tumor Necrosis Factor Gene Polymorphisms on Patients With Congestive Heart Failure , 1998 .

[59]  A. Kimura,et al.  Polymorphism of the 5′‐flanking region of the human tumor necrosis factor (TNF)‐α gene in Japanese , 1998 .

[60]  L. Notarangelo,et al.  Mutation analysis by a non‐radioactive single‐strand conformation polymorphism assay in nine families with X‐linked severe combined immunodeficiency (SCIDX1) , 1998, British journal of haematology.

[61]  C. Spitzweg,et al.  Lack of association of Graves' disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population. , 1998, European journal of endocrinology.

[62]  M. Clerici,et al.  Cytokine profiles in HIV type 1 disease and protection. , 1998, AIDS research and human retroviruses.

[63]  P. Hertzog,et al.  Recent advances in cytokines, cytokine receptors and signal transduction. , 1998, Cytokine & growth factor reviews.

[64]  É. Albuisson,et al.  IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjögren's syndrome and rheumatoid arthritis. , 1998, Clinical immunology and immunopathology.

[65]  J. Lanchbury,et al.  Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[66]  Chun Xu,et al.  Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis , 1998, Journal of Neuroimmunology.

[67]  H. Nakagawa,et al.  Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. , 1998, Journal of medical genetics.

[68]  T. Baglin,et al.  A common polymorphism in the tumour necrosis factor‐alpha gene associated with high TNF levels is not a risk factor for venous thromboembolism , 1998, British journal of haematology.

[69]  S. John,et al.  A new polymorphism in the promoter of the Interleukin 5 receptor alpha subunit (IL-5RA) gene , 1998, Immunogenetics.

[70]  G. Salles,et al.  Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. , 1998, Blood.

[71]  D. Kwiatkowski,et al.  Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[72]  David C. Jones,et al.  No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis. , 1998, Journal of hepatology.

[73]  J. Partanen,et al.  TNF microsatellite alleles a2 and b3 are not primarily associated with celiac disease in the Finnish population. , 1998, Tissue antigens.

[74]  P. Burton,et al.  Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[75]  J. Mok,et al.  Analysis of TNFB and TNFA NcoI RFLP in colorectal cancer. , 1998, Molecules and cells.

[76]  J. Bellingham,et al.  A polymorphic dinucleotide repeat in the 5’ flanking region of the human interleukin 11 (IL11) gene , 1998, Immunogenetics.

[77]  K. Selmaj,et al.  Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha , 1998, Journal of Neuroimmunology.

[78]  J. Bidwell,et al.  A novel NlaIII polymorphism in the human IL-6 promoter. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[79]  Shibasaki,et al.  Association of asthma and the interleukin‐4 promoter gene in Japanese , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[80]  J. Bidwell,et al.  Identification of a rare Bg/II polymorphism in the promoter region of the human TNF receptor type I (p55) gene. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[81]  G. Galbraith,et al.  Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype. , 1998, Journal of periodontology.

[82]  J. Bidwell,et al.  An MspA1 I polymorphism in exon 1 of the human TNF receptor type I (p55) gene. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[83]  J. Bidwell,et al.  Human cytokine gene nucleotide sequence alignments, 1998. , 1998, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[84]  W. Gauderman,et al.  Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. , 1998, Arthritis and rheumatism.

[85]  Schneider,et al.  A tumour necrosis factor‐alpha (TNF‐α) promoter polymorphism is associated with chronic hepatitis B infection , 1998 .

[86]  Albert,et al.  Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) 1β and IL‐1 receptor antagonist gene polymorphisms , 1998, European journal of clinical investigation.

[87]  S. Langabeer,et al.  IL-1 receptor antagonist gene polymorphism in patients with secondary acute myeloid leukaemia. , 1998, Cytokines, cellular & molecular therapy.

[88]  G. Gerken,et al.  Tumor necrosis factor alpha promoter polymorphism at position ‐238 is associated with chronic active hepatitis C infection , 1998, Journal of medical virology.

[89]  W. Ollier,et al.  Influence of tumour necrosis factor microsatellite polymorphisms on susceptibility to head and neck cancer. , 1998, Acta oto-laryngologica.

[90]  M. Walker,et al.  Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance , 1998, Diabetologia.

[91]  J. Todd,et al.  Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6). , 1998, Human molecular genetics.

[92]  J. Oksenberg,et al.  Limited allelic polymorphism in the human interleukin-3 gene. , 1998, Molecular and cellular probes.

[93]  J. Bidwell,et al.  Nuclear Matrix Proteins and Osteoblast Gene Expression , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[94]  M. Emi,et al.  Isolation and mapping of a polymorphic CA repeat sequence at the human interleukin 6 locus , 1998, Journal of Human Genetics.

[95]  R. Pirskanen,et al.  Polymorphisms in IL-1β and IL-1 receptor antagonist genes are associated with myasthenia gravis , 1998, Journal of Neuroimmunology.

[96]  F. Pezzetti,et al.  Lack of linkage disequilibrium between transforming growth factor alpha Taq I polymorphism and cleft lip with or without cleft palate in families from Northeastern Italy. , 1998, American journal of medical genetics.

[97]  D. Arveiler,et al.  Polymorphisms of the tumour necrosis factor‐α gene, coronary heart disease and obesity , 1998, European journal of clinical investigation.

[98]  T. Hirano,et al.  Signal TransductionThrough Cytokine Receptors , 1998 .

[99]  W. Ollier,et al.  IL-10 gene promoter polymorphisms in rheumatoid arthritis. , 1998, Scandinavian journal of rheumatology.

[100]  S. Saitoh,et al.  Correlation of a polymorphism in the interleukin-1 receptor antagonist gene with hepatic fibrosis in Japanese alcoholics. , 1998, Alcoholism, clinical and experimental research.

[101]  N. Stahl,et al.  General mechanisms of cytokine receptor signaling. , 1998, Advances in protein chemistry.

[102]  K. Badenhoop,et al.  Tumour necrosis factor beta alleles and hyperinsulinaemia in coronary artery disease. , 1998, European journal of clinical investigation.

[103]  T. Kitamura,et al.  Cytokine receptors: structures and signal transduction. , 1998, International reviews of immunology.

[104]  D. Mann,et al.  Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial. , 1998, Circulation.

[105]  K. Usadel,et al.  Interferon-gamma gene microsatellite polymorphisms in patients with Graves' disease. , 1998, Thyroid : official journal of the American Thyroid Association.

[106]  M. Hurme,et al.  IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. , 1998, European journal of immunology.

[107]  A. Kimura,et al.  Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. , 1998, Tissue antigens.

[108]  T. Hirano,et al.  Signal transduction through cytokine receptors. , 1998, International reviews of immunology.

[109]  J. Martín,et al.  Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. , 1998, Tissue antigens.

[110]  J. Partanen,et al.  High-producer allele of tumour necrosis factor-alpha is part of the susceptibility MHC haplotype in severe puumala virus-induced nephropathia epidemica. , 1998, Scandinavian journal of infectious diseases.

[111]  H. Budka,et al.  Development of HIV encephalitis in AIDS and TNF-alpha regulatory elements. , 1998, Journal of neuroimmunology.

[112]  N. Hamasaki,et al.  Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma , 1998, Nature Genetics.

[113]  L. Guilherme,et al.  Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. , 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[114]  K. Welsh,et al.  TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. , 1997, Journal of immunology.

[115]  T. Chatila,et al.  The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. , 1997, The New England journal of medicine.

[116]  C. Caruso,et al.  Modification of cytokine patterns in subjects bearing the HLA-B8,DR3 phenotype: implications for autoimmunity. , 1997, Cytokines, cellular & molecular therapy.

[117]  Jane Worthington,et al.  Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. , 1997, The Journal of rheumatology.

[118]  M. Petri,et al.  A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. , 1997, Arthritis and rheumatism.

[119]  W. B. van den Berg,et al.  Th1/Th2 cytokine balance in arthritis. , 1997, Arthritis and rheumatism.

[120]  H. Inoko,et al.  Significance of tumor necrosis factor microsatellite polymorphism in renal transplantation. , 1997, Tissue antigens.

[121]  L. Peltonen,et al.  Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCRβ, IGH, IFN-γ and IL-1ra/IL-1β loci , 1997, Journal of Neuroimmunology.

[122]  I. Hutchinson,et al.  Cytokine gene polymorphism and heart transplant rejection. , 1997, Transplantation.

[123]  B. Weinshenker,et al.  A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis , 1997, Neurology.

[124]  D. Kwiatkowski,et al.  Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. , 1997, The Journal of infectious diseases.

[125]  G Semana,et al.  Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases. , 1997, The American journal of gastroenterology.

[126]  J. Grove,et al.  Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis , 1997, Hepatology.

[127]  G. Gallagher,et al.  Association of the TNFa2 microsatellite allele with the presence of colorectal cancer. , 1997, Tissue antigens.

[128]  L C Harrison,et al.  Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? , 1997, Journal of immunology.

[129]  L. Li,et al.  Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy? , 1997, Kidney international.

[130]  A. Consiglio,et al.  Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis , 1997, Journal of Neuroimmunology.

[131]  Paul Wordsworth,et al.  Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. , 1997, Tissue antigens.

[132]  M. Todaro,et al.  Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals. , 1997, Human immunology.

[133]  J. Lieberman,et al.  Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups. , 1997, Blood.

[134]  R. Fukuda,et al.  Genes for interleukin‐2 receptor β chain, interleukin‐1 β, and schizophrenia: No evidence for the association or linkage , 1997 .

[135]  K. Usadel,et al.  Polymorphisms of tumor necrosis factor receptor 2 are not associated with insulin-dependent diabetes mellitus or Graves' disease. , 1997, Tissue antigens.

[136]  F. Breedveld,et al.  Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? , 1997, British journal of rheumatology.

[137]  P. Brandtzaeg,et al.  Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. , 1997, Gastroenterology.

[138]  E. G. de la Concha,et al.  Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. , 1997, Journal of neuroimmunology.

[139]  J. Puck,et al.  Carrier and prenatal diagnosis of X-linked severe combined immunodeficiency: mutation detection methods and utilization , 1997, Human Genetics.

[140]  S. Endres,et al.  Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. , 1997, Gut.

[141]  M. Schmid,et al.  Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in chronic lymphocytic leukaemia , 1997, British journal of haematology.

[142]  G Tantillo,et al.  HLA-B8,DR3 haplotype affects lymphocyte blood levels. , 1997, Immunological investigations.

[143]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[144]  M. Schmid,et al.  Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in hairy cell leukaemia , 1997, British Journal of Haematology.

[145]  W. Cookson,et al.  Tumour necrosis factor haplotypes and asthma. , 1997, Human molecular genetics.

[146]  W. Ollier,et al.  Tumour necrosis factor c2 microsatellite allele is associated with the rate of HIV disease progression , 1997, AIDS.

[147]  J. Puck,et al.  Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. , 1997, Blood.

[148]  H. Przuntek,et al.  Genetic predisposition to multiple sclerosis as revealed by immunoprinting , 1997, Annals of neurology.

[149]  N. Petrovsky,et al.  HLA class II-associated polymorphism of interferon-gamma production. Implications for HLA-disease association. , 1997, Human immunology.

[150]  A. E. Campbell,et al.  Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid , 1997, Infection and immunity.

[151]  A. Lerner,et al.  TH1/TH2 cytokine profile in celiac disease. , 1997, Israel journal of medical sciences.

[152]  K. Deichmann,et al.  Common polymorphisms in the coding part of the IL4-receptor gene. , 1997, Biochemical and biophysical research communications.

[153]  M. Clanet,et al.  Interleukin-1 receptor antagonist gene in multiple sclerosis , 1997, The Lancet.

[154]  R. Kurman,et al.  Analysis of cytokine profiles in patients with human papillomavirus-associated neoplasms. , 1997, Journal of the National Cancer Institute.

[155]  M. Knip,et al.  Analysis of an Interferon-γ Gene (IFNG) Polymorphism in Danish and Finnish Insulin-Dependent Diabetes Mellitus (IDDM) Patients and Control Subjects , 1997 .

[156]  C. Polman,et al.  TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients , 1997, Journal of Neuroimmunology.

[157]  M. Lazarus,et al.  An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[158]  H. Suzuki,et al.  Interleukin-1 receptor antagonist gene polymorphism in Japanese patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[159]  D. Boomsma,et al.  Genetic influence on cytokine production and fatal meningococcal disease , 1997, The Lancet.

[160]  R. Fukuda,et al.  Genes for interleukin-2 receptor beta chain, interleukin-1 beta, and schizophrenia: no evidence for the association or linkage. , 1997, American journal of medical genetics.

[161]  E. Pareja,et al.  Polymorphism at the TNF loci in rheumatoid arthritis. , 1997, Tissue antigens.

[162]  M. Knip,et al.  Analysis of an interferon-gamma gene (IFNG) polymorphism in Danish and Finnish insulin-dependent diabetes mellitus (IDDM) patients and control subjects. Danish Study Group of Diabetes in Childhood. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[163]  G. Duff,et al.  The interleukin-1 genotype as a severity factor in adult periodontal disease. , 1997, Journal of clinical periodontology.

[164]  Dieter Kube,et al.  Mapping of the human IL10 gene and further characterization of the 5’ flanking sequence , 1997, Immunogenetics.

[165]  G. Hitman,et al.  THE EFFECT OF TNF*B GENE POLYMORPHISM ON TNF‐α AND ‐β SECRETION LEVELS IN PATIENTS WITH INSULIN‐DEPENDENT DIABETES MELLITUS AND HEALTHY CONTROLS , 1996 .

[166]  R. Cuddihy,et al.  Lack of an association between alleles of interleukin-1 alpha and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population. , 1996, The Journal of clinical endocrinology and metabolism.

[167]  C. Caruso,et al.  Major histocompatibility complex regulation of cytokine production. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[168]  G. Hitman,et al.  An association between type 1 diabetes and the interleukin-1 receptor type 1 gene , 1996 .

[169]  D. Arveiler,et al.  Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. , 1996, Hypertension.

[170]  M. Parkes,et al.  Cytokine gene polymorphisms in inflammatory bowel disease. , 1996, Gut.

[171]  Paul Wordsworth,et al.  Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. , 1996, The Journal of rheumatology.

[172]  J. Mansfield,et al.  TNF2, a polymorphism of the tumour necrosis‐α gene promoter, is a component of the celiac disease major histocompatibility complex haplotype , 1996, European journal of immunology.

[173]  C. Amos,et al.  Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. , 1996, American journal of human genetics.

[174]  L. Beckman,et al.  Polymorphism in the interferon-alpha gene family. , 1996, American journal of human genetics.

[175]  P. Reitsma,et al.  Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. , 1996, Cytokine.

[176]  M. Cork,et al.  Promoter region polymorphism in the human TNF‐α gene is not associated with lichen sclerosus , 1996, Experimental dermatology.

[177]  W. Cookson,et al.  Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. , 1996, Journal of medical genetics.

[178]  C. Caruso,et al.  In vitro T cell activation in elderly individuals: failure in CD69 and CD71 expression , 1996, Mechanisms of Ageing and Development.

[179]  L. Rink,et al.  Recent Progress in the Tumor Necrosis Factor-α Field , 1996 .

[180]  J. Hillert,et al.  An interleukin 1-receptor-antagonist gene polymorphism is not associated with multiple sclerosis , 1996, Journal of Neuroimmunology.

[181]  A. Silman,et al.  Association of tumor necrosis factor microsatellite polymorphisms with HLA-DRB1*04-bearing haplotypes in rheumatoid arthritis patients. , 1996, Arthritis and rheumatism.

[182]  R. Scorza,et al.  Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. , 1996, Tissue antigens.

[183]  R. Figlin,et al.  The biology of the cytokine sequence cascade. , 1996, Seminars in oncology.

[184]  S. Kashiwagi,et al.  Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. , 1996, International immunology.

[185]  C. Cho,et al.  Systemic lupus erythematosus with nephritis is strongly associated with the TNFB*2 homozygote in the Korean population. , 1996, Human immunology.

[186]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[187]  N. Maclaren,et al.  No primary association between the 308 polymorphism in the tumor necrosis factor alpha promoter region and insulin-dependent diabetes mellitus. , 1996, Human immunology.

[188]  G. Bouma,et al.  Evidence for genetic heterogeneity in IBD: 1. The interleukin‐1 receptor antagonist in the predisposition to suffer from ulcerative colitis , 1996, European journal of gastroenterology & hepatology.

[189]  J N Weinstein,et al.  Reference databases of cytokine structure and function. , 1996, Cancer chemotherapy and biological response modifiers.

[190]  G. Hitman,et al.  The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. , 1996, European journal of immunogenetics.

[191]  M. Wang,et al.  In vivo direction of CD4 T cells to Th1 and Th2-like patterns of cytokine synthesis. , 1996, Advances in experimental medicine and biology.

[192]  J. Klinenberg,et al.  A greater variability in the 3' flanking region of the IL-6 gene in patients with systemic lupus erythematosus (SLE). , 1996, Autoimmunity.

[193]  R. Gale,et al.  The beta subunit common to the GM-CSF, IL-3 and IL-5 receptors is highly polymorphic but pathogenic point mutations in patients with acute myeloid leukaemia (AML) are rare. , 1996, Leukemia.

[194]  L. Rink,et al.  Recent progress in the tumor necrosis factor-alpha field. , 1996, International archives of allergy and immunology.

[195]  K. Fong,et al.  Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. , 1996, Annals of the Academy of Medicine, Singapore.

[196]  G. Hitman,et al.  An association between type 1 diabetes and the interleukin-1 receptor type 1 gene. The DiMe Study Group. Childhood Diabetes in Finland. , 1996, Human immunology.

[197]  G. Gallagher,et al.  A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene , 1996, Immunogenetics.

[198]  J. Hillert,et al.  Tumor necrosis factor α-308 alleles in multiple sclerosis and optic neuritis , 1995, Journal of Neuroimmunology.

[199]  G. Hayem,et al.  ABSENCE OF CORRELATION BETWEEN IL-lα INTRON 6 POLYMORPHISM AND RHEUMATOID ARTHRITIS , 1995 .

[200]  M. Roncarolo,et al.  T‐Cell Subsets and Their Cytokine Profiles in Transplantation and Tolerance , 1995, Annals of the New York Academy of Sciences.

[201]  W. R. Lamb,et al.  A genetic marker of high TNF-α production in heart transplant recipients , 1995 .

[202]  J. Crusius,et al.  Allelic polymorphism in IL‐1β and IL‐1 receptor antagonist (IL‐1Ra) genes in inflammatory bowel disease , 1995, Clinical and experimental immunology.

[203]  F. Pociot,et al.  An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis , 1995, Multiple sclerosis.

[204]  J. Blackwell,et al.  Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis , 1995, The Journal of experimental medicine.

[205]  A. Chakravarti,et al.  Association study of schizophrenia and the IL-2 receptor β chain gene , 1995 .

[206]  C. Polman,et al.  Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis , 1995, The Lancet.

[207]  A. Peña,et al.  Distribution of an NcoI polymorphism in the lymphotoxin alpha gene in Dutch patients with inflamatory bowel diseases. , 1995, Chinese medical journal.

[208]  F. Pociot,et al.  Functional Analysis of a New Polymorphism in the Human TNF α Gene Promoter , 1995, Scandinavian journal of immunology.

[209]  F. Pociot,et al.  Characterization of polymorphisms of an interleukin 1 receptor type 1 gene (IL1RI) promotor region (P2) and their relation to insulin-dependent diabetes mellitus (IDDM). The Danish Study Group of Diabetes in Childhood. , 1995, Cytokine.

[210]  D. Monos,et al.  Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus. Linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes. , 1995, Human immunology.

[211]  P. Miossec.  Pro- and antiinflammatory cytokine balance in rheumatoid arthritis. , 1995, Clinical and experimental rheumatology.

[212]  J. Puck,et al.  Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency. , 1995, American journal of human genetics.

[213]  Eric O Long,et al.  HLA-DR polymorphism affects the interaction with CD4 , 1995, The Journal of experimental medicine.

[214]  E. Albert,et al.  IMMUNOPRINTING EXCLUDES MANY POTENTIAL SUSCEPTIBILITY GENES AS PREDISPOSING TO EARLY ONSET PAUCIARTICULAR JUVENILE CHRONIC ARTHRITIS EXCEPT HLA CLASS II AND TNF , 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[215]  D. Curtis,et al.  An extended transmission/disequilibrium test (TDT) for multi‐allele marker loci , 1995, Annals of human genetics.

[216]  Sung-Hwan Park,et al.  TNFB Gene Polymorphism in Patients with Systemic Lupus Erythematosus in Korean , 1995, The Korean journal of internal medicine.

[217]  C. Mantzoros,et al.  Genetic Variability in the TNF-α Promoter Is Not Associated with Type II Diabetes Mellitus (NIDDM) , 1995 .

[218]  C. Gutiérrez,et al.  A tumor necrosis factor-β polymorphism associated with hypertriglyceridemia in non-insulin-dependent diabetes mellitus☆ , 1995 .

[219]  K. Tsuji,et al.  HLA and tumor necrosis factor beta gene polymorphisms in Okinawa lung cancer patients: comparative study with mainland Japan lung cancer patients. , 1995, Human Immunology.

[220]  M. Cork,et al.  Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis. , 1995, The Journal of investigative dermatology.

[221]  A. Blakemore,et al.  An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata. , 1995, The Journal of investigative dermatology.

[222]  M. Todaro,et al.  T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro. , 1995, Human immunology.

[223]  Y. Nagamachi,et al.  10.5‐kb homozygote of tumor necrosis factor‐beta gene is associated with a better prognosis in gastric cancer patients , 1995, Cancer.

[224]  J. Houwing-Duistermaat,et al.  Familial differences in endotoxin-induced TNF release in whole blood and peripheral blood mononuclear cells in vitro; relationship to TNF gene polymorphism , 1995 .

[225]  R. Płoski,et al.  A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism , 1995 .

[226]  J. Puck,et al.  Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency. , 1995, The Journal of clinical investigation.

[227]  D. Grennan,et al.  Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism , 1995, Clinical and experimental immunology.

[228]  Identification of susceptibility loci contributing to a complex disease using conventional segregation, linkage, and association methods , 1995, Genetic epidemiology.

[229]  J. Hillert,et al.  Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. , 1995, Journal of neuroimmunology.

[230]  C. Mantzoros,et al.  Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). , 1995, Biochemical and biophysical research communications.

[231]  C. Gutiérrez,et al.  A tumor necrosis factor-beta polymorphism associated with hypertriglyceridemia in non-insulin-dependent diabetes mellitus. , 1995, Metabolism: clinical and experimental.

[232]  A. Chakravarti,et al.  Association study of schizophrenia and the IL-2 receptor beta chain gene. , 1995, American journal of medical genetics.

[233]  I. Udalova,et al.  -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. , 1995, Journal of inflammation.

[234]  A. Blakemore,et al.  Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. , 1995, The Journal of clinical endocrinology and metabolism.

[235]  W. R. Lamb,et al.  A genetic marker of high TNF-alpha production in heart transplant recipients. , 1995, Transplantation.

[236]  R. Płoski,et al.  A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. , 1995, Arthritis and rheumatism.

[237]  D. Grennan,et al.  Lack of association between an interleukin-1 receptor antagonist gene polymorphism and systemic lupus erythematosus. , 1995, Disease markers.

[238]  D. Grennan,et al.  Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. , 1995, Disease markers.

[239]  M. Gougerot-Pocidalo,et al.  Absence of correlation between IL-1 alpha intron 6 polymorphism and rheumatoid arthritis. , 1995, British journal of rheumatology.

[240]  R. Madhok,et al.  TNF Nco‐I RFLP IS NOT AN INDEPENDENT RISK FACTOR IN RHEUMATOID ARTHRITIS , 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[241]  S. Thein,et al.  A polymorphism in the human coagulation factor V gene. , 1994, Human molecular genetics.

[242]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[243]  J. Cassiman,et al.  POLYMORPHISM OF THE TUMOUR NECROSIS FACTOR BETA GENE IN MULTIPLE SCLEROSIS AND RHEUMATOID ARTHRITIS , 1994, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[244]  J. Epplen,et al.  Dinucleotide repeat polymorphism in the human IL1A gene. , 1994, Human molecular genetics.

[245]  R. Gale,et al.  Analysis of mutations in the GM-CSF receptor alpha coding sequence in patients with acute myeloid leukaemia and haematologically normal individuals by RT-PCR-SSCP. , 1994, Leukemia.

[246]  A. Blakemore,et al.  Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. , 1994, The Journal of investigative dermatology.

[247]  C. Gutiérrez,et al.  A Tumor Necrosis Factor β-Gene Polymorphism Associated With Islet Cell Antibodies in Newly Diagnosed Type I Diabetic Patients , 1994, Diabetes Care.

[248]  C. Gordon,et al.  Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. , 1994, Arthritis and rheumatism.

[249]  B. Brinkman,et al.  Polymorphism of tumour necrosis factor‐alpha (TNF‐α) at position –308 in relation to ankylosing spondylitis , 1994, Clinical and experimental immunology.

[250]  A. Rabinovitch.  Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation? , 1994, Diabetes.

[251]  P. Nürnberg,et al.  Dinucleotide repeat polymorphism in the IL2 and IL5RA genes. , 1994, Human molecular genetics.

[252]  A. Cambon-Thomsen,et al.  Tumor necrosis factor polymorphisms in multiple sclerosis: No additional association independent of HLA , 1994, Journal of Neuroimmunology.

[253]  H. K. Lee,et al.  The tumor necrosis factor beta * 1 allele is linked significantly to HLA-DR8 in Koreans with atrophic autoimmune thyroiditis who are positive for thyrotropin receptor blocking antibody. , 1994, Journal of Korean medical science.

[254]  J. Mansfield,et al.  Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. , 1994, Gastroenterology.

[255]  Y. Nagamachi,et al.  The study of tumor necrosis factor beta gene polymorphism in lung cancer patients , 1994, Cancer.

[256]  L. V. D. van de Putte,et al.  A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha , 1994, European journal of immunology.

[257]  F. Pociot,et al.  Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes : evidence for polygenecity in man , 1994 .

[258]  C. Gutiérrez,et al.  A tumor necrosis factor beta-gene polymorphism associated with islet cell antibodies in newly diagnosed type I diabetic patients. , 1994, Diabetes care.

[259]  M. Meurer,et al.  Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis. , 1994, Dermatology.

[260]  F. Pociot,et al.  Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes--evidence for polygenicity in man. Danish Study Group of Diabetes in Childhood. , 1994, Autoimmunity.

[261]  L. Glimcher,et al.  Regulation of cytokine gene expression in T helper cell subsets. , 1994, Journal of immunology.

[262]  D. Kwiatkowski,et al.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. , 1994, Nature.

[263]  W. Bodmer,et al.  TaqI RFLP for the IL2RA locus. , 1994, Human molecular genetics.

[264]  F. Pociot,et al.  No independent association between a tumor necrosis factor‐α promotor region polymorphism and insulin‐dependent diabetes mellitus , 1993, European journal of immunology.

[265]  A. Ruiz-Linares.  Dinucleotide repeat polymorphism in the interferon-gamma (IFNG) gene. , 1993, Human molecular genetics.

[266]  G. Hitman,et al.  Autoimmune renal disease and tumour necrosis factor beta gene polymorphism. , 1993, Clinical nephrology.

[267]  P. Miossec.  Acting on the cytokine balance to control auto-immunity and chronic inflammation. , 1993, European cytokine network.

[268]  A. Blakemore,et al.  Genetic polymorphism of human interleukin‐1α , 1993 .

[269]  D. Chaplin,et al.  Highly informative typing of the human TNF locus using six adjacent polymorphic markers. , 1993, Genomics.

[270]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[271]  F. Pociot,et al.  Diabetes mellitus in cystic fibrosis: genetic and immunological markers , 1993, Acta paediatrica.

[272]  J. Murray,et al.  Linkage localization of TGFB2 and the human homeobox gene HLX1 to chromosome 1q. , 1993, Genomics.

[273]  F. Pociot,et al.  An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles , 1993, The Journal of experimental medicine.

[274]  A. Cambon-Thomsen,et al.  Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF‐a and TNF‐0 by human mononuclear cells: a possible link to insulin‐dependent diabetes mellitus , 1993 .

[275]  G. Duff,et al.  Polymorphic tandem repeat region in interleukin-1 alpha intron 6. , 1993, Human genetics.

[276]  A. Cambon-Thomsen,et al.  Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. , 1993, European journal of immunology.

[277]  A. Blakemore,et al.  Genetic polymorphism of human interleukin-1 alpha. , 1993, European journal of immunology.

[278]  J. Ilonen,et al.  Tumour Necrosis Factor‐β Gene RFLP Alleles in Finnish IDDM Hapiotypes , 1992 .

[279]  B. Horsthemke,et al.  A NEW RESTRICTION FRAGMENT LENGTH POLYMORPHISM OF THE HUMAN TNF‐B GENE DETECTED BY Asp HI DIGEST , 1992, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[280]  H. Inoko,et al.  RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behçet's disease. , 1992, Investigative ophthalmology & visual science.

[281]  D. Kwiatkowski,et al.  Dinucleotide repeat polymorphism at the IFNA locus (9p22). , 1992, Human molecular genetics.

[282]  R. Zitnik,et al.  Cytokine-cytokine interactions in the context of cytokine networking. , 1992, American journal of respiratory cell and molecular biology.

[283]  A. Blakemore,et al.  Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). , 1992, Human molecular genetics.

[284]  A. Blakemore,et al.  Single base polymorphism at −511 in the human interleukin-1β gene (IL1β) , 1992 .

[285]  F. Pociot,et al.  A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro , 1992 .

[286]  T. Atsumi.  [Tumor necrosis factor alpha in systemic lupus erythematosus: evaluation by restriction fragment length polymorphism and production by peripheral blood mononuclear cells]. , 1992, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

[287]  G. Gaidano,et al.  TaqI RFLP in the interferon gamma receptor 1 gene (IFNGR1) on human chromosome 6q. , 1992, Nucleic acids research.

[288]  M. Lokki,et al.  Tumour Necrosis Factor B Gene Polymorphism in Relation to Complotype in Couples with Spontaneous Abortions and in Control Families , 1992, Scandinavian journal of immunology.

[289]  K. Usadel,et al.  Tumor necrosis factor beta gene polymorphisms in Graves' disease. , 1992, The Journal of clinical endocrinology and metabolism.

[290]  J. Ilonen,et al.  Tumour necrosis factor-beta gene RFLP alleles in Finnish IDDM haplotypes. The Childhood Diabetes in Finland (DiMe) Study Group. , 1992, Scandinavian journal of immunology.

[291]  F. Pociot,et al.  A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. , 1992, European journal of clinical investigation.

[292]  N. Nicola,et al.  A review of cytokine structures. , 1992, Protein sequences & data analysis.

[293]  U. Spengler,et al.  Allelic Variation in the TNF‐β Gene Does Not Explain the Low TNF‐β Response in Patients With Primary Biliary Cirrhosis , 1991, Scandinavian journal of immunology.

[294]  H. Jansen,et al.  Functional subsets of allergen-reactive human CD4+ T cells. , 1991, Immunology today.

[295]  P. Bossù,et al.  Activation and Functions of CD4+ T‐Cell Subsets , 1991, Immunological reviews.

[296]  A. Kelso,et al.  Heterogeneity in Lymphokine Profiles of CD4+ and CD8+ T Cells and Clones Activated in vivo and in vitro , 1991, Immunological reviews.

[297]  I. Udalova,et al.  DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. , 1991, Journal of immunology.

[298]  M. Brennan,et al.  Dinucleotide repeat polymorphism in the lL-2Rβ gene , 1991 .

[299]  R. Willemze,et al.  Repeat polymorphisms in the interleukin-4 gene (IL4) , 1991, Nucleic Acids Res..

[300]  S. Naylor,et al.  Dinucleotide repeat polymorphism in the human interleukin 1, alpha gene (IL1A). , 1991, Nucleic acids research.

[301]  G. V. van Eys,et al.  Restriction fragment length polymorphism of the tumor necrosis factor region in patients with ankylosing spondylitis. , 1991, Arthritis and rheumatism.

[302]  D. S. Rath,et al.  Dinucleotide repeat polymorphism at the human interleukin 9 gene. , 1991, Nucleic acids research.

[303]  F. Pociot,et al.  A Tumour Necrosis Factor Beta Gene Polymorphism in Relation to Monokine Secretion and Insulin‐Dependent Diabetes Mellitus , 1991, Scandinavian journal of immunology.

[304]  U. Spengler,et al.  Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.

[305]  M. Brennan,et al.  Dinucleotide repeat polymorphism in the IL-2R beta gene. , 1991, Nucleic acids research.

[306]  T. Standiford,et al.  Cellular and molecular mechanisms of cytokine networking. , 1991, Agents and actions. Supplements.

[307]  T. Mosmann.  Cytokine secretion patterns and cross-regulation of T cell subsets , 1991, Immunologic research.

[308]  S. K. Burke,et al.  Activation of functionally distinct subsets of CD4+ T lymphocytes. , 1991, Research in immunology.

[309]  G. Lutfalla,et al.  HindIII RFLP at the human IFNAR locus. , 1990, Nucleic acids research.

[310]  H. Hobbs,et al.  A high frequency of length polymorphisms in repeated sequences adjacent to Alu sequences. , 1990, American journal of human genetics.

[311]  L. Fugger,et al.  Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis , 1990, Journal of Neuroimmunology.

[312]  K. Badenhoop.  Immunogenetic markers for autoimmune diseases of the endocrine system. , 1990, Klinische Wochenschrift.

[313]  P. Bingley,et al.  TNF‐alpha GENE POLYMORPHISMS: ASSOCIATION WITH TYPE I (INSULIN‐DEPENDENT) DIABETES MELLITUS , 1989, Journal of immunogenetics.

[314]  L. Fugger,et al.  IL‐6 GENE POLYMORPHISM IN RHEUMATOID ARTHRITIS, PAUCIARTICULAR JUVENILE RHEUMATOID ARTHRITIS, SYSTEMIC LUPUS ERYTHEMATOSUS, AND IN HEALTHY DANES , 1989, Journal of immunogenetics.

[315]  H. Volk,et al.  Lack of correlation between BglII RFLP in the human interleukin 6 gene and rheumatoid arthritis. , 1989, Nucleic acids research.

[316]  A. Bowcock,et al.  Rapid detection and sequencing of alleles in the 3' flanking region of the interleukin-6 gene. , 1989, Nucleic acids research.

[317]  F. Balkwill,et al.  The cytokine network. , 1989, Immunology today.

[318]  L. Fugger,et al.  NcoI Restriction Fragment Length Polymorphism (RFLP) of the Tumour Necrosis Factor (TNFα) Region in Primary Biliary Cirrhosis and in Healthy Danes , 1989, Scandinavian journal of immunology.

[319]  L. Fugger,et al.  NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF alpha) region in four autoimmune diseases. , 1989, Tissue antigens.

[320]  L. Fugger,et al.  MspI polymorphism in the human interleukin 6 (IL 6) gene. , 1989, Nucleic acids research.

[321]  H. Kreipe,et al.  A BglII RFLP demonstrated for the Il-3 gene in normal human blood cells and leukemias. , 1989, Nucleic acids research.

[322]  K. Badenhoop,et al.  TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus. , 1989, Diabetologia.

[323]  George I. Bell,et al.  A Taq I polymorphism for the human transforming growth factor alpha gene (TGFA) , 1987, Nucleic Acids Res..

[324]  D. Goeddel,et al.  Human Immune Interferon (IFN-γ) Gene Sequence and Structure , 1983 .

[325]  D. Goeddel,et al.  Human immune interferon (IFN-gamma) gene sequence and structure. , 1983, Basic life sciences.

[326]  P. Pitha,et al.  Methylation and a polymorphic restriction site adjacent to human beta-interferon gene. , 1982, DNA.

[327]  W. J. Morginson.  [Lupus erythematosus]. , 1960, Revista medica hondurena.

[328]  C. E. Field.  Myeloid Leukaemia. , 1939, Proceedings of the Royal Society of Medicine.